Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM-MSCs for Alcoholic Liver Cirrhosis
NCT01741090Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Sep 2009
- Primary completion
- Jun 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous bone marrow derived mesenchymal stromal cells in alcoholic liver cirrhosis, sponsored by Yonsei University. Primary endpoint: Improvement of Liver Histologic grade at 6 months. Status: unknown.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
alcoholic liver cirrhosis
Beyond the preview
Go deeper on NCT01741090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741090.